Mode of action of pertuzumab in combination with trastuzumab plus docetaxel therapy in a HER2-positive breast cancer xenograft model.

Autor: YORIKO YAMASHITA-KASHIMA1, SEI SHU1, KEIGO YOROZU1, YOICHIRO MORIYA1, NAOKI HARADA1 haradanok@chugai-pharm.co.jp
Zdroj: Oncology Letters. Oct2017, Vol. 14 Issue 4, p4197-4205. 9p.
Databáze: Academic Search Ultimate